The effect of caffeine on peripheral vascular resistance in isolated perfused guinea pig hind limbs

Journal of Cardiovascular Pharmacology

Volumn 42, Issue 4, 2003, Pages 506-510

  Brodmann, Marianne ^a,b   Lischnig, Ulrike ^a   Lueger, Andreas ^a   Pilger, Ernst ^a   Stark, Gerhard ^a  

^a UNIVERSITY HOSPITAL GRAZ   (Austria)

^b UNIVERSITY OF GRAZ   (Austria)

Author keywords

Adenosine; Adenosine receptors A1 and A2; Caffeine; Hypoxia induced vasodilatation; Isolated perfused guinea pig hind limb; Methylxanthines; Peripheral arterial occlusive disease (PAOD)

Indexed keywords

4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR; ADENOSINE A2 RECEPTOR ANTAGONIST; ADENOSINE RECEPTOR BLOCKING AGENT; ALLOXAZINE; CAFFEINE; FLAVINE MONONUCLEOTIDE; ILOPROST; METHYLXANTHINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; GUINEA PIG; HYPOXIA; ISOLATED ORGAN; LIMB PERFUSION; MALE; NONHUMAN; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; STEADY STATE; VASCULAR RESISTANCE; VASODILATATION;

ADENOSINE; ANIMALS; ANOXIA; CAFFEINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLAVINS; GUINEA PIGS; HINDLIMB; ILIAC ARTERY; ILOPROST; MALE; NITROGEN; NOREPINEPHRINE; PERFUSION; TRIAZINES; TRIAZOLES; VASCULAR RESISTANCE; VASOCONSTRICTION; VASODILATION;

EID: 0141753978     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200310000-00008     Document Type: Article

References (25)

1. Daly JW, Fredholm BB. Caffeine: an untypical drug of dependence. Drug Alcohol Depend. 1998;51:199-206.
2. Sawynok J. Pharmacological rationale for the clinical use of caffeine. Drugs. 1995;49:37-50.
3. Grobbee DE, Rimm EB, Giovannucci E, et al. Coffee, caffeine and cardiovascular disease in men. N Engl J Med. 1990;323:1026-1032.
4. Jee SH, He J, Whelton PK, et al. The effect of chronic coffee drinking on blood pressure: a meta-analysis of controlled clinical trials. Hypertension. 1999;33:647-652.
5. 2A receptors. Trends Pharmacol Sci. 1996;17:364-372.
6. Klotz KN, Hessling J, Hegler J, et al. Comparative pharmacology of human adenosine receptor subtypes: characterization of stably transfected receptors in CHO cells. Naunyn Schmiedebergs Arch Pharmacol. 1998;357:1-9.
7. Cavalcante JW, Santos PR Jr, Menezes MG, et al. Influence of caffeine on blood pressure and platelet aggregation. Arq Bras Cardiol. 2000;75:97-105.
8. Selvaggio A, Periti M, Miano L, et al. Association between habitual coffee consumption and blood pressure levels. J Hypertens. 1990;8:585-590.
9. 2A receptors. Circulation. 2000;102:285-289.
10. 2A receptors and their function in human platelets. Circulation. 1999;99:2499-2502.
11. Casiglia E, Paleari CD, Petucco S, et al. Haemodynamic effects of coffee and purified caffeine in normal volunteers: a placebo-controlled clinical study. J Hum Hypertens. 1992;6:95-99.
12. Kono S, Shinchi K, Ikeda N, et al. Green tea consumption and serum lipid profiles: a cross-sectional study in northern Kyushu, Japan. Prev Med. 1992;21:526-531.
13. Green MS, Harari G. Association of serum lipoproteins and health-related habits with coffee and tea consumption in free-living subjects examined in the Israeli CORDIS Study. Prev Med. 1992;21:532-545.
14. Zhang Y, Wells JN. The effect of chronic caffeine administration on peripheral adenosine receptors. J Pharmacol Exp Ther. 1990;254:757-763.
15. Mohiuddin AA, Bath FJ, Bath PM. Theophylline, aminophylline, caffeine and analogues for acute ischaemic stroke. Cochrane-Database Syst Rev. 2000;2:CD000211.
16. MacLean DA, Sinoway LI, Leuenberger U. Systemic hypoxia elevates skeletal muscle interstitial adenosine levels in humans. Circulation. 1998;98:1990-1992.
17. Skinner MR, Marshall JM. Studies on the roles of ATP, adenosine and nitric oxide in mediating muscle vasodilatation induced in the rat by acute systemic hypoxia. J Physiol (Lond). 1996;495:553-560.
18. Jacobson KA, van Galen JM, Williams M. Adenosine receptors: pharmacology, structure-activity relationships, and therapeutical potential. Med Chem. 1992;35:407-422.
19. 2 receptors in femoral vasodilatation induced by intra-arterial adensoine in rabbits. Eur J Pharmacol. 1998;353:257-264.
20. 1-induced vasorelaxation in porcine coronary arteries. J Pharmacol Exp Ther. 1992;260:1128-1132.
21. Brodmann M, Stelzer I, Friedl I, et al. Comparison of the effect of prostaglandin E1, prostacycline and adenosine on peripheral vascular resistance. Int Angiol. 2001;10:31-33.
22. Centorrio T, Versaci A, Ciccolo A, et al. Our experience in using a synthetic prostacyclin analog in the treatment of critical ischemia of the extremities. G Chir. 1998;19:399-403.
23. Bounameaux H, Wutschert R. Drug treatment strategies for peripheral obliterative arteriopathy. Drugs. 1998;56:17-23.
24. Leuenberger URS, Gray K, Herr MD. Adenosine contributes to hypoxia-induced forearm vasodilatation in humans. J Appl Physiol. 1999;87:2218-2224.
25. Pasini FL, Guideri F, Picano E, et al. Increase in plasma adenosine during brain ischemia in man: a study during transient ischemic attacks, and stroke. Brain Res Bull. 2000;51:327-330.